Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
- 14 September 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (18), 5606-5608
- https://doi.org/10.1158/1078-0432.ccr-09-1575
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma. Because myeloma is an incurable malignancy, strategies to delay or prevent progression in high-risk patients are of considerable importance. (Clin Cancer Res 2009;15(18):5606–8)Keywords
Other Versions
This publication has 15 references indexed in Scilit:
- The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance—Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover MarkerClinical Cancer Research, 2009
- A monoclonal gammopathy precedes multiple myeloma in most patientsBlood, 2009
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- Pathogenesis of myeloma bone diseaseLeukemia, 2008
- Prevalence of Monoclonal Gammopathy of Undetermined Significance: Study of 52,802 Persons in Nagasaki City, JapanMayo Clinic Proceedings, 2007
- Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in GhanaMayo Clinic Proceedings, 2007
- Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United StatesBlood, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosisBlood, 2004
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002